Most drugs used today have only one mechanism of action and it is both difficult and expensive to manufacture drugs with multiple functions. Researchers at the NNF-funded research center, CEMBID, at Aarhus University have recently found a way to create more stable nanostructures that can assemble biomolecules with different functions, which in combination e.g., can provide more effective cancer medicine.

AU researcher, Associate Professor Brigitte Stadler, and an intercontinental team of researchers, have received a prestigious international grant to study how important parts of the cell, the nucleus and mitochondria, communicate.

ODIN has reserved DKK 23.9 million for six new research projects that will pave the way for new drugs to treat a wide range of medical conditions. iNANO researchers Duncan Sutherland, Jørgen Kjems, and Daniel Otzen take part in these projects on Parkinson's disease, schizophrenia, diabetes, renal diseases and cancer.